IBDEI2C6 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,37322,0)
;;=E11.59^^146^1915^18
;;^UTILITY(U,$J,358.3,37322,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37322,1,3,0)
;;=3^DM Type 2 w/ Circulatory Compl NEC
;;^UTILITY(U,$J,358.3,37322,1,4,0)
;;=4^E11.59
;;^UTILITY(U,$J,358.3,37322,2)
;;=^5002652
;;^UTILITY(U,$J,358.3,37323,0)
;;=E11.610^^146^1915^27
;;^UTILITY(U,$J,358.3,37323,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37323,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropath Arthropathy
;;^UTILITY(U,$J,358.3,37323,1,4,0)
;;=4^E11.610
;;^UTILITY(U,$J,358.3,37323,2)
;;=^5002653
;;^UTILITY(U,$J,358.3,37324,0)
;;=E11.618^^146^1915^22
;;^UTILITY(U,$J,358.3,37324,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37324,1,3,0)
;;=3^DM Type 2 w/ Diab Arthropathy NEC
;;^UTILITY(U,$J,358.3,37324,1,4,0)
;;=4^E11.618
;;^UTILITY(U,$J,358.3,37324,2)
;;=^5002654
;;^UTILITY(U,$J,358.3,37325,0)
;;=E11.620^^146^1915^24
;;^UTILITY(U,$J,358.3,37325,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37325,1,3,0)
;;=3^DM Type 2 w/ Diab Dermatitis
;;^UTILITY(U,$J,358.3,37325,1,4,0)
;;=4^E11.620
;;^UTILITY(U,$J,358.3,37325,2)
;;=^5002655
;;^UTILITY(U,$J,358.3,37326,0)
;;=E11.622^^146^1915^34
;;^UTILITY(U,$J,358.3,37326,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37326,1,3,0)
;;=3^DM Type 2 w/ Skin Ulcer NEC
;;^UTILITY(U,$J,358.3,37326,1,4,0)
;;=4^E11.622
;;^UTILITY(U,$J,358.3,37326,2)
;;=^5002657
;;^UTILITY(U,$J,358.3,37327,0)
;;=E11.628^^146^1915^33
;;^UTILITY(U,$J,358.3,37327,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37327,1,3,0)
;;=3^DM Type 2 w/ Skin Compl NEC
;;^UTILITY(U,$J,358.3,37327,1,4,0)
;;=4^E11.628
;;^UTILITY(U,$J,358.3,37327,2)
;;=^5002658
;;^UTILITY(U,$J,358.3,37328,0)
;;=E11.69^^146^1915^19
;;^UTILITY(U,$J,358.3,37328,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37328,1,3,0)
;;=3^DM Type 2 w/ Complications NEC
;;^UTILITY(U,$J,358.3,37328,1,4,0)
;;=4^E11.69
;;^UTILITY(U,$J,358.3,37328,2)
;;=^5002664
;;^UTILITY(U,$J,358.3,37329,0)
;;=E11.8^^146^1915^20
;;^UTILITY(U,$J,358.3,37329,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37329,1,3,0)
;;=3^DM Type 2 w/ Complications,Unspec
;;^UTILITY(U,$J,358.3,37329,1,4,0)
;;=4^E11.8
;;^UTILITY(U,$J,358.3,37329,2)
;;=^5002665
;;^UTILITY(U,$J,358.3,37330,0)
;;=E10.51^^146^1915^13
;;^UTILITY(U,$J,358.3,37330,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37330,1,3,0)
;;=3^DM Type 1 w/ Diab Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,37330,1,4,0)
;;=4^E10.51
;;^UTILITY(U,$J,358.3,37330,2)
;;=^5002610
;;^UTILITY(U,$J,358.3,37331,0)
;;=E10.52^^146^1915^12
;;^UTILITY(U,$J,358.3,37331,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37331,1,3,0)
;;=3^DM Type 1 w/ Diab Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,37331,1,4,0)
;;=4^E10.52
;;^UTILITY(U,$J,358.3,37331,2)
;;=^5002611
;;^UTILITY(U,$J,358.3,37332,0)
;;=E10.59^^146^1915^1
;;^UTILITY(U,$J,358.3,37332,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37332,1,3,0)
;;=3^DM Type 1 w/ Circulatory Compl NEC
;;^UTILITY(U,$J,358.3,37332,1,4,0)
;;=4^E10.59
;;^UTILITY(U,$J,358.3,37332,2)
;;=^5002612
;;^UTILITY(U,$J,358.3,37333,0)
;;=E10.610^^146^1915^10
;;^UTILITY(U,$J,358.3,37333,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37333,1,3,0)
;;=3^DM Type 1 w/ Diab Neuropathy Arthropathy
;;^UTILITY(U,$J,358.3,37333,1,4,0)
;;=4^E10.610
;;^UTILITY(U,$J,358.3,37333,2)
;;=^5002613
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2C6 3745 printed Oct 16, 2024@18:26:40 Page 2
IBDEI2C6 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,37322,0)
+2 ;;=E11.59^^146^1915^18
+3 ;;^UTILITY(U,$J,358.3,37322,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,37322,1,3,0)
+6 ;;=3^DM Type 2 w/ Circulatory Compl NEC
+7 ;;^UTILITY(U,$J,358.3,37322,1,4,0)
+8 ;;=4^E11.59
+9 ;;^UTILITY(U,$J,358.3,37322,2)
+10 ;;=^5002652
+11 ;;^UTILITY(U,$J,358.3,37323,0)
+12 ;;=E11.610^^146^1915^27
+13 ;;^UTILITY(U,$J,358.3,37323,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,37323,1,3,0)
+16 ;;=3^DM Type 2 w/ Diab Neuropath Arthropathy
+17 ;;^UTILITY(U,$J,358.3,37323,1,4,0)
+18 ;;=4^E11.610
+19 ;;^UTILITY(U,$J,358.3,37323,2)
+20 ;;=^5002653
+21 ;;^UTILITY(U,$J,358.3,37324,0)
+22 ;;=E11.618^^146^1915^22
+23 ;;^UTILITY(U,$J,358.3,37324,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,37324,1,3,0)
+26 ;;=3^DM Type 2 w/ Diab Arthropathy NEC
+27 ;;^UTILITY(U,$J,358.3,37324,1,4,0)
+28 ;;=4^E11.618
+29 ;;^UTILITY(U,$J,358.3,37324,2)
+30 ;;=^5002654
+31 ;;^UTILITY(U,$J,358.3,37325,0)
+32 ;;=E11.620^^146^1915^24
+33 ;;^UTILITY(U,$J,358.3,37325,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,37325,1,3,0)
+36 ;;=3^DM Type 2 w/ Diab Dermatitis
+37 ;;^UTILITY(U,$J,358.3,37325,1,4,0)
+38 ;;=4^E11.620
+39 ;;^UTILITY(U,$J,358.3,37325,2)
+40 ;;=^5002655
+41 ;;^UTILITY(U,$J,358.3,37326,0)
+42 ;;=E11.622^^146^1915^34
+43 ;;^UTILITY(U,$J,358.3,37326,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,37326,1,3,0)
+46 ;;=3^DM Type 2 w/ Skin Ulcer NEC
+47 ;;^UTILITY(U,$J,358.3,37326,1,4,0)
+48 ;;=4^E11.622
+49 ;;^UTILITY(U,$J,358.3,37326,2)
+50 ;;=^5002657
+51 ;;^UTILITY(U,$J,358.3,37327,0)
+52 ;;=E11.628^^146^1915^33
+53 ;;^UTILITY(U,$J,358.3,37327,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,37327,1,3,0)
+56 ;;=3^DM Type 2 w/ Skin Compl NEC
+57 ;;^UTILITY(U,$J,358.3,37327,1,4,0)
+58 ;;=4^E11.628
+59 ;;^UTILITY(U,$J,358.3,37327,2)
+60 ;;=^5002658
+61 ;;^UTILITY(U,$J,358.3,37328,0)
+62 ;;=E11.69^^146^1915^19
+63 ;;^UTILITY(U,$J,358.3,37328,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,37328,1,3,0)
+66 ;;=3^DM Type 2 w/ Complications NEC
+67 ;;^UTILITY(U,$J,358.3,37328,1,4,0)
+68 ;;=4^E11.69
+69 ;;^UTILITY(U,$J,358.3,37328,2)
+70 ;;=^5002664
+71 ;;^UTILITY(U,$J,358.3,37329,0)
+72 ;;=E11.8^^146^1915^20
+73 ;;^UTILITY(U,$J,358.3,37329,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,37329,1,3,0)
+76 ;;=3^DM Type 2 w/ Complications,Unspec
+77 ;;^UTILITY(U,$J,358.3,37329,1,4,0)
+78 ;;=4^E11.8
+79 ;;^UTILITY(U,$J,358.3,37329,2)
+80 ;;=^5002665
+81 ;;^UTILITY(U,$J,358.3,37330,0)
+82 ;;=E10.51^^146^1915^13
+83 ;;^UTILITY(U,$J,358.3,37330,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,37330,1,3,0)
+86 ;;=3^DM Type 1 w/ Diab Periph Angiopathy w/o Gangrene
+87 ;;^UTILITY(U,$J,358.3,37330,1,4,0)
+88 ;;=4^E10.51
+89 ;;^UTILITY(U,$J,358.3,37330,2)
+90 ;;=^5002610
+91 ;;^UTILITY(U,$J,358.3,37331,0)
+92 ;;=E10.52^^146^1915^12
+93 ;;^UTILITY(U,$J,358.3,37331,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,37331,1,3,0)
+96 ;;=3^DM Type 1 w/ Diab Periph Angiopathy w/ Gangrene
+97 ;;^UTILITY(U,$J,358.3,37331,1,4,0)
+98 ;;=4^E10.52
+99 ;;^UTILITY(U,$J,358.3,37331,2)
+100 ;;=^5002611
+101 ;;^UTILITY(U,$J,358.3,37332,0)
+102 ;;=E10.59^^146^1915^1
+103 ;;^UTILITY(U,$J,358.3,37332,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,37332,1,3,0)
+106 ;;=3^DM Type 1 w/ Circulatory Compl NEC
+107 ;;^UTILITY(U,$J,358.3,37332,1,4,0)
+108 ;;=4^E10.59
+109 ;;^UTILITY(U,$J,358.3,37332,2)
+110 ;;=^5002612
+111 ;;^UTILITY(U,$J,358.3,37333,0)
+112 ;;=E10.610^^146^1915^10
+113 ;;^UTILITY(U,$J,358.3,37333,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,37333,1,3,0)
+116 ;;=3^DM Type 1 w/ Diab Neuropathy Arthropathy
+117 ;;^UTILITY(U,$J,358.3,37333,1,4,0)
+118 ;;=4^E10.610
+119 ;;^UTILITY(U,$J,358.3,37333,2)
+120 ;;=^5002613
